Charles Schwab Investment Management Inc Delcath Systems, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 12,977 shares of DCTH stock, worth $206,593. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,977Holding current value
$206,593% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DCTH
# of Institutions
79Shares Held
7.02MCall Options Held
198KPut Options Held
41.7K-
Vivo Capital, LLC Palo Alto, CA1.71MShares$27.2 Million3.93% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.39MShares$22.1 Million6.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.22MShares$19.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA289KShares$4.6 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO259KShares$4.12 Million0.07% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $137M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...